| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Docosahexaenoic Acids | 187 | 2023 | 875 | 28.690 |
Why?
|
| Lipoxins | 207 | 2022 | 411 | 22.390 |
Why?
|
| Inflammation Mediators | 106 | 2023 | 1889 | 14.340 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 136 | 2011 | 226 | 13.000 |
Why?
|
| Eicosapentaenoic Acid | 76 | 2022 | 582 | 9.730 |
Why?
|
| Inflammation | 198 | 2023 | 10578 | 9.620 |
Why?
|
| Neutrophils | 170 | 2023 | 3711 | 8.430 |
Why?
|
| Fatty Acids, Unsaturated | 36 | 2023 | 546 | 7.320 |
Why?
|
| Peritonitis | 38 | 2019 | 365 | 6.570 |
Why?
|
| Aspirin | 103 | 2023 | 3278 | 6.280 |
Why?
|
| Macrophages | 87 | 2023 | 5655 | 6.180 |
Why?
|
| Anti-Inflammatory Agents | 51 | 2023 | 1788 | 5.710 |
Why?
|
| Eicosanoids | 56 | 2022 | 278 | 5.700 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 74 | 2020 | 2276 | 5.470 |
Why?
|
| Receptors, Lipoxin | 38 | 2023 | 84 | 5.450 |
Why?
|
| Lipid Metabolism | 53 | 2020 | 1887 | 5.420 |
Why?
|
| Receptors, Formyl Peptide | 36 | 2023 | 145 | 5.380 |
Why?
|
| Phagocytosis | 43 | 2023 | 1538 | 4.720 |
Why?
|
| Escherichia coli Infections | 16 | 2021 | 532 | 4.460 |
Why?
|
| Lipids | 44 | 2023 | 3302 | 3.960 |
Why?
|
| Fatty Acids, Omega-3 | 41 | 2023 | 1341 | 3.720 |
Why?
|
| Phagocytes | 11 | 2023 | 297 | 3.570 |
Why?
|
| Leukotrienes | 41 | 2022 | 255 | 3.490 |
Why?
|
| Leukocytes | 49 | 2021 | 2039 | 3.430 |
Why?
|
| Leukotriene B4 | 45 | 2020 | 293 | 3.170 |
Why?
|
| Receptors, G-Protein-Coupled | 19 | 2023 | 1221 | 2.840 |
Why?
|
| Goblet Cells | 19 | 2023 | 287 | 2.630 |
Why?
|
| Escherichia coli | 22 | 2023 | 4214 | 2.590 |
Why?
|
| Regeneration | 13 | 2021 | 1485 | 2.570 |
Why?
|
| Metabolome | 13 | 2022 | 881 | 2.570 |
Why?
|
| Metabolomics | 22 | 2019 | 1467 | 2.500 |
Why?
|
| Animals | 375 | 2023 | 168561 | 2.460 |
Why?
|
| Tandem Mass Spectrometry | 26 | 2023 | 1157 | 2.190 |
Why?
|
| Conjunctiva | 15 | 2022 | 493 | 2.140 |
Why?
|
| Vagus Nerve | 5 | 2019 | 437 | 2.110 |
Why?
|
| Chromatography, Liquid | 32 | 2023 | 977 | 2.030 |
Why?
|
| Neutrophil Infiltration | 19 | 2019 | 390 | 1.980 |
Why?
|
| Mice | 194 | 2023 | 81045 | 1.920 |
Why?
|
| Arachidonate 5-Lipoxygenase | 23 | 2018 | 144 | 1.900 |
Why?
|
| Signal Transduction | 74 | 2022 | 23387 | 1.670 |
Why?
|
| Planarians | 6 | 2021 | 52 | 1.660 |
Why?
|
| Prostaglandins | 19 | 2019 | 405 | 1.650 |
Why?
|
| Arachidonate 15-Lipoxygenase | 19 | 2023 | 85 | 1.610 |
Why?
|
| Stereoisomerism | 34 | 2023 | 625 | 1.600 |
Why?
|
| Arachidonic Acids | 36 | 2006 | 299 | 1.470 |
Why?
|
| Cells, Cultured | 83 | 2022 | 19223 | 1.470 |
Why?
|
| Zymosan | 16 | 2018 | 124 | 1.460 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 23 | 2020 | 329 | 1.430 |
Why?
|
| Carbon Monoxide | 5 | 2018 | 531 | 1.420 |
Why?
|
| Receptors, Cell Surface | 27 | 2010 | 2867 | 1.400 |
Why?
|
| Arachidonate 12-Lipoxygenase | 13 | 2015 | 80 | 1.360 |
Why?
|
| Mucins | 13 | 2022 | 564 | 1.320 |
Why?
|
| Biosynthetic Pathways | 4 | 2019 | 137 | 1.310 |
Why?
|
| Cyclooxygenase Inhibitors | 14 | 2019 | 371 | 1.260 |
Why?
|
| Humans | 441 | 2024 | 742088 | 1.240 |
Why?
|
| Molecular Structure | 31 | 2021 | 1907 | 1.230 |
Why?
|
| Chemotaxis, Leukocyte | 20 | 2014 | 675 | 1.220 |
Why?
|
| Reperfusion Injury | 12 | 2020 | 1025 | 1.180 |
Why?
|
| Cell Communication | 21 | 2019 | 1619 | 1.180 |
Why?
|
| Polyisoprenyl Phosphates | 6 | 2005 | 36 | 1.170 |
Why?
|
| Monocytes | 22 | 2019 | 2593 | 1.140 |
Why?
|
| Leukotriene D4 | 6 | 2018 | 38 | 1.130 |
Why?
|
| Receptors, Leukotriene B4 | 12 | 2016 | 94 | 1.120 |
Why?
|
| Apoptosis | 24 | 2021 | 9715 | 1.030 |
Why?
|
| Leukotriene A4 | 14 | 2017 | 26 | 1.010 |
Why?
|
| Periodontitis | 10 | 2017 | 553 | 0.990 |
Why?
|
| Cell Movement | 34 | 2021 | 5212 | 0.990 |
Why?
|
| Fatty Acids, Essential | 5 | 2021 | 95 | 0.980 |
Why?
|
| Vagotomy | 3 | 2019 | 83 | 0.950 |
Why?
|
| Receptors, Chemokine | 8 | 2018 | 669 | 0.940 |
Why?
|
| Staphylococcus aureus | 4 | 2022 | 1449 | 0.940 |
Why?
|
| Exudates and Transudates | 8 | 2019 | 171 | 0.930 |
Why?
|
| Thromboxane B2 | 7 | 2014 | 152 | 0.920 |
Why?
|
| Sepsis | 10 | 2019 | 2589 | 0.910 |
Why?
|
| Calcium | 29 | 2022 | 5753 | 0.900 |
Why?
|
| Chemotaxis | 9 | 2018 | 607 | 0.890 |
Why?
|
| Dinoprostone | 16 | 2022 | 600 | 0.880 |
Why?
|
| Lipoxygenase | 18 | 2019 | 74 | 0.860 |
Why?
|
| Autacoids | 5 | 2014 | 17 | 0.850 |
Why?
|
| Macrophage Activation | 4 | 2019 | 558 | 0.820 |
Why?
|
| Isoenzymes | 15 | 2004 | 1725 | 0.820 |
Why?
|
| Mice, Inbred Strains | 14 | 2018 | 1827 | 0.800 |
Why?
|
| Wound Healing | 10 | 2022 | 2781 | 0.800 |
Why?
|
| Leukotriene Antagonists | 6 | 2019 | 127 | 0.800 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2021 | 40 | 0.790 |
Why?
|
| Phospholipase D | 7 | 2020 | 70 | 0.790 |
Why?
|
| Blood Platelets | 21 | 2014 | 2506 | 0.780 |
Why?
|
| Endothelium, Vascular | 19 | 2013 | 4455 | 0.780 |
Why?
|
| Pneumonia | 9 | 2023 | 2117 | 0.760 |
Why?
|
| Asthma | 14 | 2019 | 5955 | 0.750 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2023 | 413 | 0.750 |
Why?
|
| Arachidonic Acid | 26 | 2019 | 434 | 0.740 |
Why?
|
| Acute Disease | 18 | 2019 | 7141 | 0.730 |
Why?
|
| Aggressive Periodontitis | 2 | 2015 | 59 | 0.720 |
Why?
|
| Disease Models, Animal | 40 | 2021 | 18006 | 0.710 |
Why?
|
| Lung | 22 | 2023 | 9826 | 0.700 |
Why?
|
| Cell Adhesion | 22 | 2013 | 3139 | 0.700 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2023 | 256 | 0.700 |
Why?
|
| Mice, Inbred BALB C | 29 | 2019 | 6382 | 0.690 |
Why?
|
| Pain | 11 | 2023 | 4961 | 0.690 |
Why?
|
| Neuroimmunomodulation | 2 | 2018 | 152 | 0.690 |
Why?
|
| Cyclooxygenase 2 | 18 | 2022 | 611 | 0.680 |
Why?
|
| Gene Expression Regulation | 20 | 2016 | 12071 | 0.680 |
Why?
|
| Ocular Physiological Phenomena | 1 | 2019 | 70 | 0.670 |
Why?
|
| Spleen | 13 | 2020 | 2359 | 0.660 |
Why?
|
| Bronchial Hyperreactivity | 3 | 2007 | 319 | 0.650 |
Why?
|
| Staphylococcal Infections | 2 | 2022 | 1398 | 0.650 |
Why?
|
| Mice, Inbred C57BL | 52 | 2022 | 21821 | 0.650 |
Why?
|
| Dexamethasone | 5 | 2023 | 1949 | 0.650 |
Why?
|
| MicroRNAs | 7 | 2019 | 3731 | 0.640 |
Why?
|
| Male | 152 | 2023 | 349538 | 0.640 |
Why?
|
| Arthritis | 3 | 2023 | 658 | 0.640 |
Why?
|
| Acute Lung Injury | 4 | 2016 | 378 | 0.640 |
Why?
|
| Tears | 4 | 2020 | 252 | 0.640 |
Why?
|
| CHO Cells | 9 | 2018 | 1407 | 0.640 |
Why?
|
| SRS-A | 11 | 1992 | 156 | 0.630 |
Why?
|
| Recombinant Proteins | 22 | 2018 | 6608 | 0.620 |
Why?
|
| Immunity, Innate | 13 | 2018 | 2956 | 0.620 |
Why?
|
| Hemorrhagic Disorders | 1 | 2017 | 36 | 0.620 |
Why?
|
| Esters | 4 | 2015 | 210 | 0.610 |
Why?
|
| Cytokines | 33 | 2021 | 7317 | 0.610 |
Why?
|
| Cricetinae | 11 | 2018 | 2471 | 0.600 |
Why?
|
| Pneumonia, Pneumococcal | 2 | 2015 | 126 | 0.600 |
Why?
|
| Chromatography, High Pressure Liquid | 26 | 2011 | 1574 | 0.580 |
Why?
|
| Epoxide Hydrolases | 4 | 2020 | 122 | 0.580 |
Why?
|
| Mass Spectrometry | 23 | 2013 | 2203 | 0.570 |
Why?
|
| Periodontal Ligament | 4 | 2022 | 118 | 0.560 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 23 | 2008 | 222 | 0.560 |
Why?
|
| Cricetulus | 5 | 2018 | 817 | 0.550 |
Why?
|
| Tumor Necrosis Factor-alpha | 18 | 2013 | 4414 | 0.550 |
Why?
|
| Calcimycin | 25 | 2011 | 222 | 0.540 |
Why?
|
| Cytophagocytosis | 2 | 2012 | 6 | 0.540 |
Why?
|
| Cysteine | 3 | 2019 | 873 | 0.530 |
Why?
|
| T-Lymphocytes | 8 | 2021 | 10163 | 0.530 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2016 | 75 | 0.520 |
Why?
|
| Receptors, Eicosanoid | 6 | 2014 | 12 | 0.500 |
Why?
|
| Small Molecule Libraries | 2 | 2018 | 721 | 0.500 |
Why?
|
| Histamine | 5 | 2023 | 507 | 0.500 |
Why?
|
| Communicable Diseases | 1 | 2023 | 878 | 0.500 |
Why?
|
| Nanomedicine | 2 | 2014 | 304 | 0.500 |
Why?
|
| Superoxides | 19 | 2005 | 386 | 0.480 |
Why?
|
| Neuroprotective Agents | 6 | 2020 | 941 | 0.480 |
Why?
|
| Antimetabolites | 1 | 2014 | 125 | 0.480 |
Why?
|
| Rats | 42 | 2023 | 24265 | 0.470 |
Why?
|
| Receptors, Leukotriene | 7 | 2018 | 123 | 0.470 |
Why?
|
| Leukocytes, Mononuclear | 8 | 2020 | 1835 | 0.460 |
Why?
|
| Chronic Periodontitis | 1 | 2014 | 101 | 0.460 |
Why?
|
| Structure-Activity Relationship | 17 | 2018 | 3133 | 0.460 |
Why?
|
| Drug Design | 8 | 2011 | 1078 | 0.460 |
Why?
|
| Ligands | 15 | 2023 | 3293 | 0.450 |
Why?
|
| Chemokines | 9 | 2019 | 954 | 0.450 |
Why?
|
| Models, Immunological | 2 | 2014 | 527 | 0.450 |
Why?
|
| Capillary Permeability | 4 | 2001 | 798 | 0.440 |
Why?
|
| Mice, Knockout | 27 | 2019 | 14554 | 0.440 |
Why?
|
| Annexin A1 | 2 | 2023 | 20 | 0.430 |
Why?
|
| Glutathione | 2 | 2019 | 586 | 0.430 |
Why?
|
| Ascitic Fluid | 3 | 2010 | 192 | 0.420 |
Why?
|
| Glomerular Mesangium | 4 | 1997 | 108 | 0.420 |
Why?
|
| Hydroxyprostaglandin Dehydrogenases | 3 | 2006 | 30 | 0.420 |
Why?
|
| Bronchoalveolar Lavage Fluid | 11 | 2023 | 766 | 0.420 |
Why?
|
| Immune System | 1 | 2017 | 804 | 0.410 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 6 | 2023 | 867 | 0.410 |
Why?
|
| Blood Vessels | 1 | 2018 | 1124 | 0.410 |
Why?
|
| Fatty Acids | 9 | 2024 | 1806 | 0.410 |
Why?
|
| Rats, Sprague-Dawley | 22 | 2022 | 8300 | 0.410 |
Why?
|
| Homeostasis | 10 | 2020 | 3335 | 0.410 |
Why?
|
| Leukotriene E4 | 2 | 2011 | 79 | 0.410 |
Why?
|
| Hypersensitivity | 6 | 2018 | 1093 | 0.410 |
Why?
|
| 15-Oxoprostaglandin 13-Reductase | 2 | 2001 | 5 | 0.400 |
Why?
|
| Bone Regeneration | 1 | 2014 | 427 | 0.400 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 3 | 2008 | 276 | 0.400 |
Why?
|
| Blood Coagulation | 1 | 2017 | 1126 | 0.390 |
Why?
|
| Skin | 10 | 2021 | 4353 | 0.390 |
Why?
|
| Dose-Response Relationship, Drug | 24 | 2018 | 10943 | 0.390 |
Why?
|
| Inosine Monophosphate | 2 | 2001 | 10 | 0.390 |
Why?
|
| Milk, Human | 1 | 2015 | 490 | 0.380 |
Why?
|
| Cell Adhesion Molecules | 5 | 2011 | 1599 | 0.380 |
Why?
|
| Cell Migration Inhibition | 6 | 2008 | 96 | 0.380 |
Why?
|
| Neutrophil Activation | 7 | 2010 | 186 | 0.380 |
Why?
|
| Heme Oxygenase-1 | 1 | 2013 | 381 | 0.370 |
Why?
|
| Cornea | 1 | 2019 | 1497 | 0.370 |
Why?
|
| Fish Oils | 4 | 2022 | 469 | 0.370 |
Why?
|
| Alcohol Oxidoreductases | 2 | 2001 | 170 | 0.370 |
Why?
|
| Blood Cells | 2 | 2011 | 309 | 0.370 |
Why?
|
| Cyclic AMP | 5 | 2019 | 1470 | 0.370 |
Why?
|
| Venous Thrombosis | 1 | 2019 | 1237 | 0.360 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2013 | 550 | 0.350 |
Why?
|
| Nanostructures | 1 | 2014 | 550 | 0.350 |
Why?
|
| Cell Line | 25 | 2018 | 15994 | 0.350 |
Why?
|
| Models, Biological | 16 | 2018 | 9581 | 0.340 |
Why?
|
| Adenosine Diphosphate | 1 | 2010 | 425 | 0.340 |
Why?
|
| Up-Regulation | 9 | 2018 | 4211 | 0.340 |
Why?
|
| Photoreceptor Cells | 1 | 2010 | 244 | 0.340 |
Why?
|
| Lymphocytes | 2 | 2017 | 2614 | 0.340 |
Why?
|
| Subcutaneous Fat | 1 | 2012 | 391 | 0.330 |
Why?
|
| Blood | 3 | 2008 | 598 | 0.330 |
Why?
|
| Porphyromonas gingivalis | 4 | 2015 | 169 | 0.330 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2018 | 2915 | 0.330 |
Why?
|
| Pruritus | 2 | 2022 | 359 | 0.330 |
Why?
|
| Macrophages, Peritoneal | 4 | 2010 | 251 | 0.320 |
Why?
|
| Pneumonia, Viral | 3 | 2021 | 3236 | 0.320 |
Why?
|
| Epoxy Compounds | 4 | 2016 | 136 | 0.320 |
Why?
|
| Membrane Proteins | 19 | 2018 | 7873 | 0.320 |
Why?
|
| Aldehydes | 1 | 2009 | 167 | 0.320 |
Why?
|
| Benzene Derivatives | 1 | 2008 | 54 | 0.320 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2015 | 3239 | 0.320 |
Why?
|
| Pharmacology | 2 | 2021 | 103 | 0.320 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2011 | 215 | 0.310 |
Why?
|
| Molecular Sequence Data | 22 | 2009 | 18112 | 0.310 |
Why?
|
| Cell Differentiation | 14 | 2016 | 11470 | 0.310 |
Why?
|
| Oxidative Stress | 8 | 2015 | 3081 | 0.310 |
Why?
|
| Principal Component Analysis | 3 | 2017 | 939 | 0.310 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 12 | 2014 | 4751 | 0.300 |
Why?
|
| Leukotriene C4 | 7 | 2011 | 97 | 0.300 |
Why?
|
| Kinetics | 26 | 2010 | 6474 | 0.300 |
Why?
|
| Parathyroid Hormone | 1 | 2014 | 1801 | 0.300 |
Why?
|
| Mice, Transgenic | 13 | 2017 | 9735 | 0.300 |
Why?
|
| Models, Chemical | 8 | 2013 | 626 | 0.300 |
Why?
|
| Immunologic Factors | 2 | 2015 | 1575 | 0.300 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 16 | 2009 | 361 | 0.300 |
Why?
|
| Multigene Family | 2 | 2009 | 1102 | 0.300 |
Why?
|
| Eosinophils | 5 | 2023 | 953 | 0.290 |
Why?
|
| Adaptive Immunity | 3 | 2018 | 712 | 0.290 |
Why?
|
| Calcium Signaling | 4 | 2016 | 721 | 0.290 |
Why?
|
| Metabolic Diseases | 1 | 2013 | 657 | 0.290 |
Why?
|
| Macrophages, Alveolar | 5 | 2015 | 407 | 0.290 |
Why?
|
| Intracellular Fluid | 3 | 2004 | 203 | 0.290 |
Why?
|
| HL-60 Cells | 4 | 2010 | 365 | 0.280 |
Why?
|
| Enzyme Inhibitors | 10 | 2015 | 3800 | 0.280 |
Why?
|
| Dermatitis | 2 | 2018 | 197 | 0.280 |
Why?
|
| Platelet Activation | 1 | 2010 | 671 | 0.280 |
Why?
|
| Tritium | 8 | 2015 | 746 | 0.280 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 4 | 1997 | 902 | 0.280 |
Why?
|
| DNA Primers | 7 | 2015 | 2892 | 0.280 |
Why?
|
| Cannabinoids | 1 | 2009 | 166 | 0.280 |
Why?
|
| Spinal Cord | 5 | 2021 | 1807 | 0.280 |
Why?
|
| Proteomics | 5 | 2016 | 3618 | 0.280 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 12 | 2018 | 3862 | 0.270 |
Why?
|
| TRPV Cation Channels | 3 | 2012 | 235 | 0.270 |
Why?
|
| Computational Biology | 4 | 2014 | 3518 | 0.270 |
Why?
|
| Epithelial Cells | 7 | 2007 | 3678 | 0.270 |
Why?
|
| Oxygenases | 1 | 2005 | 60 | 0.270 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2005 | 68 | 0.260 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3130 | 0.260 |
Why?
|
| Systems Biology | 1 | 2009 | 469 | 0.260 |
Why?
|
| Chemotactic Factors | 6 | 2001 | 199 | 0.260 |
Why?
|
| Brain | 15 | 2021 | 26343 | 0.260 |
Why?
|
| NF-kappa B | 9 | 2018 | 2500 | 0.260 |
Why?
|
| Phospholipases A | 4 | 2005 | 216 | 0.260 |
Why?
|
| Dietary Fats | 4 | 2012 | 2017 | 0.260 |
Why?
|
| Oxidoreductases | 3 | 2008 | 424 | 0.260 |
Why?
|
| Lipoxygenase Inhibitors | 5 | 2019 | 94 | 0.260 |
Why?
|
| Stem Cells | 4 | 2022 | 3563 | 0.250 |
Why?
|
| Receptors, CCR5 | 2 | 2006 | 497 | 0.250 |
Why?
|
| Lidocaine | 1 | 2008 | 542 | 0.250 |
Why?
|
| Neurons | 9 | 2017 | 9325 | 0.250 |
Why?
|
| Isoflurane | 1 | 2008 | 381 | 0.250 |
Why?
|
| Phospholipids | 10 | 2013 | 781 | 0.250 |
Why?
|
| Osteoporosis | 2 | 2004 | 1581 | 0.250 |
Why?
|
| Membrane Microdomains | 1 | 2005 | 202 | 0.250 |
Why?
|
| Neoplasms | 8 | 2024 | 21596 | 0.240 |
Why?
|
| Bone Marrow | 2 | 2014 | 2941 | 0.240 |
Why?
|
| Microglia | 4 | 2021 | 1261 | 0.240 |
Why?
|
| Fura-2 | 6 | 2022 | 109 | 0.240 |
Why?
|
| Administration, Inhalation | 2 | 2018 | 1104 | 0.240 |
Why?
|
| DNA, Complementary | 6 | 2002 | 2049 | 0.240 |
Why?
|
| Diacylglycerol Kinase | 1 | 2004 | 48 | 0.240 |
Why?
|
| Peptides | 6 | 2023 | 4392 | 0.240 |
Why?
|
| Hyperalgesia | 2 | 2011 | 502 | 0.230 |
Why?
|
| Pneumonia, Bacterial | 2 | 2018 | 316 | 0.230 |
Why?
|
| Arrestins | 2 | 2015 | 74 | 0.230 |
Why?
|
| Diglycerides | 1 | 2004 | 176 | 0.230 |
Why?
|
| RNA Interference | 1 | 2012 | 2890 | 0.230 |
Why?
|
| Rabbits | 9 | 2017 | 4886 | 0.230 |
Why?
|
| Conjunctivitis, Allergic | 2 | 2016 | 129 | 0.230 |
Why?
|
| Papio | 2 | 2015 | 656 | 0.230 |
Why?
|
| Receptor, Cannabinoid, CB2 | 2 | 2015 | 49 | 0.230 |
Why?
|
| Phosphatidylinositols | 3 | 1991 | 291 | 0.230 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 2023 | 61 | 0.230 |
Why?
|
| Pandemics | 6 | 2023 | 8328 | 0.230 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2023 | 82 | 0.230 |
Why?
|
| Biocatalysis | 2 | 2014 | 167 | 0.230 |
Why?
|
| Tetradecanoylphorbol Acetate | 9 | 1997 | 821 | 0.220 |
Why?
|
| Isomerism | 7 | 2011 | 201 | 0.220 |
Why?
|
| Myocardial Infarction | 4 | 2020 | 11690 | 0.220 |
Why?
|
| Organ Culture Techniques | 2 | 2018 | 808 | 0.220 |
Why?
|
| Adipose Tissue | 3 | 2015 | 3278 | 0.220 |
Why?
|
| Atherosclerosis | 6 | 2017 | 3428 | 0.220 |
Why?
|
| Oxylipins | 2 | 2022 | 49 | 0.210 |
Why?
|
| Female | 67 | 2023 | 379592 | 0.210 |
Why?
|
| Blotting, Western | 8 | 2018 | 5180 | 0.210 |
Why?
|
| Tumor Cells, Cultured | 12 | 2002 | 6313 | 0.210 |
Why?
|
| Algorithms | 4 | 2007 | 13853 | 0.210 |
Why?
|
| Spectrophotometry, Ultraviolet | 9 | 2007 | 220 | 0.210 |
Why?
|
| Anesthetics | 1 | 2008 | 538 | 0.210 |
Why?
|
| Down-Regulation | 5 | 2014 | 3001 | 0.210 |
Why?
|
| Leukemia, Promyelocytic, Acute | 2 | 1993 | 233 | 0.200 |
Why?
|
| Cell Hypoxia | 3 | 2019 | 675 | 0.200 |
Why?
|
| Bronchitis | 1 | 2002 | 201 | 0.200 |
Why?
|
| Chagas Disease | 2 | 2018 | 166 | 0.200 |
Why?
|
| Amino Acid Sequence | 14 | 2009 | 13814 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2004 | 1284 | 0.200 |
Why?
|
| Immunosuppressive Agents | 2 | 2013 | 4147 | 0.200 |
Why?
|
| Lipoxygenases | 3 | 2020 | 13 | 0.200 |
Why?
|
| Phospholipases A2 | 6 | 2022 | 202 | 0.200 |
Why?
|
| Biological Factors | 1 | 2002 | 164 | 0.200 |
Why?
|
| Trypanosoma cruzi | 2 | 2018 | 198 | 0.200 |
Why?
|
| Graft Rejection | 2 | 2014 | 4393 | 0.200 |
Why?
|
| Conjunctival Diseases | 1 | 2022 | 121 | 0.200 |
Why?
|
| Sex Characteristics | 2 | 2017 | 2585 | 0.200 |
Why?
|
| RNA, Messenger | 17 | 2011 | 13029 | 0.200 |
Why?
|
| Opioid Peptides | 1 | 2001 | 42 | 0.200 |
Why?
|
| Arachidonate Lipoxygenases | 6 | 1990 | 19 | 0.200 |
Why?
|
| Neuralgia | 2 | 2021 | 568 | 0.190 |
Why?
|
| Organ Specificity | 4 | 2014 | 2003 | 0.190 |
Why?
|
| Thrombin | 7 | 2014 | 598 | 0.190 |
Why?
|
| Colitis | 4 | 2017 | 1149 | 0.190 |
Why?
|
| Oxidoreductases Acting on Sulfur Group Donors | 2 | 2017 | 32 | 0.190 |
Why?
|
| Rheumatic Diseases | 1 | 2007 | 590 | 0.190 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2017 | 1499 | 0.190 |
Why?
|
| Toxoplasma | 5 | 2006 | 150 | 0.190 |
Why?
|
| Alveolar Bone Loss | 4 | 2014 | 383 | 0.190 |
Why?
|
| AMP Deaminase | 1 | 2000 | 6 | 0.190 |
Why?
|
| Drug Evaluation, Preclinical | 4 | 2015 | 1372 | 0.190 |
Why?
|
| Hemolysin Proteins | 1 | 2020 | 113 | 0.190 |
Why?
|
| Phosphatidic Acids | 5 | 1983 | 49 | 0.190 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2021 | 164 | 0.190 |
Why?
|
| Prostaglandin D2 | 3 | 2012 | 122 | 0.180 |
Why?
|
| Base Sequence | 10 | 2010 | 12797 | 0.180 |
Why?
|
| Amides | 2 | 2015 | 458 | 0.180 |
Why?
|
| Databases, Factual | 2 | 2006 | 7716 | 0.180 |
Why?
|
| Solid Phase Extraction | 2 | 2018 | 28 | 0.180 |
Why?
|
| Terminology as Topic | 5 | 2011 | 1548 | 0.180 |
Why?
|
| Clinical Trials as Topic | 4 | 2022 | 7901 | 0.180 |
Why?
|
| Conjunctivitis | 1 | 2021 | 158 | 0.180 |
Why?
|
| Lipid Bilayers | 4 | 2004 | 381 | 0.180 |
Why?
|
| Transfection | 7 | 2010 | 5892 | 0.180 |
Why?
|
| Endotoxins | 2 | 2020 | 525 | 0.180 |
Why?
|
| Oligopeptides | 4 | 2000 | 1176 | 0.180 |
Why?
|
| Kidney Glomerulus | 4 | 1997 | 697 | 0.180 |
Why?
|
| Lymphocyte Activation | 5 | 2016 | 5519 | 0.170 |
Why?
|
| Anti-Asthmatic Agents | 2 | 2007 | 533 | 0.170 |
Why?
|
| Binding Sites | 7 | 2018 | 6115 | 0.170 |
Why?
|
| Allergens | 4 | 2018 | 1314 | 0.170 |
Why?
|
| Granuloma | 1 | 2021 | 315 | 0.170 |
Why?
|
| Streptococcus pneumoniae | 2 | 2015 | 712 | 0.170 |
Why?
|
| Glucocorticoids | 3 | 2023 | 2107 | 0.170 |
Why?
|
| Nanoparticles | 1 | 2011 | 1902 | 0.170 |
Why?
|
| GTP-Binding Proteins | 4 | 2002 | 970 | 0.170 |
Why?
|
| P-Selectin | 6 | 2011 | 600 | 0.170 |
Why?
|
| Host-Pathogen Interactions | 3 | 2018 | 1477 | 0.170 |
Why?
|
| Glomerulonephritis | 3 | 1997 | 372 | 0.170 |
Why?
|
| Nerve Growth Factors | 2 | 2014 | 576 | 0.170 |
Why?
|
| Astrocytes | 2 | 2022 | 1266 | 0.170 |
Why?
|
| Binding, Competitive | 8 | 2010 | 1159 | 0.170 |
Why?
|
| Interleukin-12 | 5 | 2006 | 579 | 0.170 |
Why?
|
| Platelet Activating Factor | 3 | 2014 | 149 | 0.170 |
Why?
|
| MAP Kinase Signaling System | 4 | 2018 | 1525 | 0.170 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2019 | 625 | 0.170 |
Why?
|
| Receptors, Peptide | 2 | 2002 | 272 | 0.170 |
Why?
|
| Ketorolac | 1 | 2019 | 77 | 0.170 |
Why?
|
| Bronchi | 2 | 2003 | 840 | 0.170 |
Why?
|
| Vascular Diseases | 2 | 2020 | 1155 | 0.170 |
Why?
|
| Cell Aggregation | 13 | 1991 | 244 | 0.170 |
Why?
|
| Gene Expression | 7 | 2018 | 7790 | 0.170 |
Why?
|
| Keratinocytes | 4 | 2021 | 797 | 0.170 |
Why?
|
| Nutrigenomics | 2 | 2016 | 23 | 0.170 |
Why?
|
| Kidney Diseases | 3 | 2018 | 2145 | 0.170 |
Why?
|
| Biomimetic Materials | 2 | 2014 | 179 | 0.170 |
Why?
|
| Interleukin-8 | 5 | 2008 | 689 | 0.170 |
Why?
|
| Wound Infection | 1 | 2021 | 240 | 0.160 |
Why?
|
| Endothelial Cells | 3 | 2020 | 3455 | 0.160 |
Why?
|
| Anti-Allergic Agents | 1 | 2000 | 141 | 0.160 |
Why?
|
| Ciona intestinalis | 1 | 2018 | 11 | 0.160 |
Why?
|
| Glycoconjugates | 1 | 2018 | 87 | 0.160 |
Why?
|
| Mucin 5AC | 1 | 2018 | 93 | 0.160 |
Why?
|
| Cannabinol | 1 | 2018 | 9 | 0.160 |
Why?
|
| Lymph Nodes | 4 | 2016 | 3465 | 0.160 |
Why?
|
| Erythrocyte Membrane | 1 | 2019 | 442 | 0.160 |
Why?
|
| Laboratory Proficiency Testing | 1 | 2017 | 19 | 0.160 |
Why?
|
| Respiratory Therapy | 1 | 2018 | 132 | 0.160 |
Why?
|
| Osteomyelitis | 1 | 2022 | 402 | 0.150 |
Why?
|
| Respiratory System | 1 | 2001 | 555 | 0.150 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2019 | 195 | 0.150 |
Why?
|
| Hypolipidemic Agents | 2 | 2011 | 604 | 0.150 |
Why?
|
| Lymphatic Diseases | 1 | 2019 | 324 | 0.150 |
Why?
|
| Administration, Topical | 4 | 2005 | 688 | 0.150 |
Why?
|
| L-Selectin | 3 | 2008 | 213 | 0.150 |
Why?
|
| Liposomes | 5 | 1989 | 758 | 0.150 |
Why?
|
| Transcription Factor AP-1 | 2 | 2013 | 317 | 0.150 |
Why?
|
| Swine | 7 | 2022 | 5934 | 0.150 |
Why?
|
| Cyclooxygenase 1 | 4 | 2006 | 104 | 0.150 |
Why?
|
| Citrobacter rodentium | 1 | 2017 | 65 | 0.150 |
Why?
|
| Flow Cytometry | 6 | 2017 | 5975 | 0.150 |
Why?
|
| Glutathione Transferase | 1 | 2019 | 595 | 0.150 |
Why?
|
| Receptors, Immunologic | 5 | 2005 | 1423 | 0.150 |
Why?
|
| Neuroglia | 1 | 2003 | 925 | 0.150 |
Why?
|
| Neoplasms, Experimental | 2 | 2021 | 1274 | 0.150 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2018 | 66 | 0.150 |
Why?
|
| Cytochrome Reductases | 1 | 2016 | 9 | 0.150 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2016 | 1837 | 0.150 |
Why?
|
| Diabetic Neuropathies | 1 | 2021 | 410 | 0.150 |
Why?
|
| Dietary Supplements | 5 | 2023 | 3294 | 0.150 |
Why?
|
| Blast Injuries | 1 | 2021 | 302 | 0.150 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2020 | 326 | 0.150 |
Why?
|
| Dendritic Cells | 5 | 2014 | 2723 | 0.150 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2021 | 324 | 0.150 |
Why?
|
| Major Histocompatibility Complex | 1 | 2000 | 935 | 0.140 |
Why?
|
| Complement C5a | 2 | 2014 | 107 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 3 | 2012 | 7153 | 0.140 |
Why?
|
| Type C Phospholipases | 4 | 2020 | 292 | 0.140 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 1996 | 58 | 0.140 |
Why?
|
| Retinal Pigment Epithelium | 2 | 2010 | 302 | 0.140 |
Why?
|
| Mice, Obese | 2 | 2020 | 424 | 0.140 |
Why?
|
| Reactive Oxygen Species | 3 | 2010 | 2077 | 0.140 |
Why?
|
| Ear, External | 3 | 2004 | 160 | 0.140 |
Why?
|
| Lung Injury | 2 | 2018 | 436 | 0.140 |
Why?
|
| Ligases | 1 | 1998 | 332 | 0.140 |
Why?
|
| Random Allocation | 3 | 2016 | 2425 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 4 | 2016 | 6171 | 0.140 |
Why?
|
| Phosphorylation | 5 | 2019 | 8436 | 0.140 |
Why?
|
| Tissue Distribution | 3 | 2013 | 2335 | 0.140 |
Why?
|
| Fibrinogen | 1 | 2019 | 894 | 0.140 |
Why?
|
| Edema | 2 | 2016 | 790 | 0.140 |
Why?
|
| Radioligand Assay | 3 | 2008 | 379 | 0.140 |
Why?
|
| Models, Molecular | 7 | 2006 | 5454 | 0.140 |
Why?
|
| Immunity, Cellular | 2 | 2019 | 1606 | 0.140 |
Why?
|
| Molecular Targeted Therapy | 3 | 2018 | 2723 | 0.140 |
Why?
|
| Monokines | 3 | 2000 | 75 | 0.130 |
Why?
|
| Enzyme Activation | 7 | 2020 | 3701 | 0.130 |
Why?
|
| Adipocytes | 2 | 2019 | 1182 | 0.130 |
Why?
|
| Chemokine CXCL2 | 3 | 2000 | 111 | 0.130 |
Why?
|
| Blood Proteins | 3 | 2008 | 1122 | 0.130 |
Why?
|
| Wounds and Injuries | 3 | 2018 | 2400 | 0.130 |
Why?
|
| Cell Separation | 2 | 2017 | 1749 | 0.130 |
Why?
|
| Erythrocytes | 2 | 2019 | 2452 | 0.130 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2017 | 186 | 0.130 |
Why?
|
| Species Specificity | 2 | 2018 | 2479 | 0.130 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 5 | 2011 | 320 | 0.130 |
Why?
|
| Glycolysis | 1 | 2019 | 825 | 0.130 |
Why?
|
| Aging | 1 | 2014 | 8626 | 0.130 |
Why?
|
| Arsenazo III | 4 | 1983 | 4 | 0.130 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2018 | 199 | 0.130 |
Why?
|
| Fibroblasts | 4 | 2016 | 4143 | 0.130 |
Why?
|
| Acetyltransferases | 1 | 2016 | 234 | 0.130 |
Why?
|
| Animals, Genetically Modified | 3 | 2004 | 1546 | 0.130 |
Why?
|
| Dry Eye Syndromes | 2 | 2019 | 382 | 0.130 |
Why?
|
| Obesity | 5 | 2020 | 12705 | 0.130 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2013 | 1504 | 0.130 |
Why?
|
| Adult | 30 | 2021 | 213712 | 0.130 |
Why?
|
| Cell Physiological Phenomena | 1 | 1996 | 154 | 0.130 |
Why?
|
| Ganglia, Spinal | 3 | 2012 | 517 | 0.130 |
Why?
|
| Cardiovascular Diseases | 2 | 2011 | 15108 | 0.130 |
Why?
|
| Platelet Adhesiveness | 2 | 2011 | 161 | 0.130 |
Why?
|
| Dental Cementum | 1 | 2014 | 52 | 0.130 |
Why?
|
| Root Planing | 1 | 2014 | 68 | 0.130 |
Why?
|
| Mycobacterium tuberculosis | 3 | 2014 | 1825 | 0.130 |
Why?
|
| Mucous Membrane | 4 | 2008 | 670 | 0.130 |
Why?
|
| Cytochrome P-450 Enzyme System | 3 | 2013 | 419 | 0.130 |
Why?
|
| Nerve Degeneration | 1 | 2019 | 748 | 0.130 |
Why?
|
| Protective Agents | 2 | 2017 | 156 | 0.130 |
Why?
|
| Chronic Disease | 7 | 2021 | 9144 | 0.130 |
Why?
|
| Ionophores | 4 | 1982 | 108 | 0.130 |
Why?
|
| Interleukin-1 | 6 | 2004 | 1262 | 0.130 |
Why?
|
| Myocardium | 4 | 2020 | 4775 | 0.120 |
Why?
|
| Dental Scaling | 1 | 2014 | 102 | 0.120 |
Why?
|
| Intra-Abdominal Fat | 2 | 2017 | 591 | 0.120 |
Why?
|
| Bacterial Toxins | 1 | 2020 | 933 | 0.120 |
Why?
|
| Joints | 1 | 2016 | 326 | 0.120 |
Why?
|
| Vitamin B Complex | 1 | 2017 | 288 | 0.120 |
Why?
|
| B-Lymphocyte Subsets | 2 | 2014 | 246 | 0.120 |
Why?
|
| Insect Vectors | 1 | 2015 | 134 | 0.120 |
Why?
|
| Antigen-Antibody Complex | 3 | 2014 | 517 | 0.120 |
Why?
|
| Intestinal Diseases | 1 | 2019 | 531 | 0.120 |
Why?
|
| Protein Kinases | 1 | 2021 | 1638 | 0.120 |
Why?
|
| Periodontal Pocket | 1 | 2014 | 166 | 0.120 |
Why?
|
| Cochlea | 1 | 2021 | 828 | 0.120 |
Why?
|
| Spodoptera | 1 | 2014 | 153 | 0.120 |
Why?
|
| Cell-Derived Microparticles | 1 | 2016 | 168 | 0.120 |
Why?
|
| Mechanical Phenomena | 1 | 2015 | 140 | 0.120 |
Why?
|
| Lipocalins | 1 | 2015 | 170 | 0.120 |
Why?
|
| Antigens, CD | 4 | 2002 | 4024 | 0.120 |
Why?
|
| Eosinophilia | 3 | 2000 | 531 | 0.120 |
Why?
|
| Plasmodium berghei | 1 | 2015 | 168 | 0.120 |
Why?
|
| Serum Amyloid A Protein | 2 | 2007 | 121 | 0.120 |
Why?
|
| Intestinal Mucosa | 4 | 2017 | 3038 | 0.120 |
Why?
|
| Heart Ventricles | 2 | 2018 | 3801 | 0.120 |
Why?
|
| Lipopolysaccharides | 5 | 2022 | 2211 | 0.120 |
Why?
|
| Cell Proliferation | 8 | 2019 | 10472 | 0.120 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 2014 | 810 | 0.120 |
Why?
|
| Peroxidase | 2 | 2009 | 610 | 0.120 |
Why?
|
| Middle Aged | 26 | 2023 | 213127 | 0.120 |
Why?
|
| Toxoplasmosis, Animal | 2 | 2005 | 17 | 0.120 |
Why?
|
| Fatty Alcohols | 2 | 2007 | 23 | 0.120 |
Why?
|
| Glycols | 2 | 2007 | 59 | 0.120 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2015 | 143 | 0.120 |
Why?
|
| Indomethacin | 4 | 2002 | 331 | 0.120 |
Why?
|
| Analgesics | 2 | 2011 | 1037 | 0.120 |
Why?
|
| Bodily Secretions | 3 | 2021 | 23 | 0.120 |
Why?
|
| Peritoneal Cavity | 2 | 2012 | 148 | 0.110 |
Why?
|
| Electric Stimulation | 1 | 2018 | 1770 | 0.110 |
Why?
|
| Alveolar Process | 1 | 2014 | 293 | 0.110 |
Why?
|
| Glucose Intolerance | 1 | 2017 | 577 | 0.110 |
Why?
|
| Catalysis | 3 | 2015 | 760 | 0.110 |
Why?
|
| C-Reactive Protein | 2 | 2007 | 3766 | 0.110 |
Why?
|
| Osteoclasts | 2 | 2008 | 729 | 0.110 |
Why?
|
| Ventricular Function | 1 | 2015 | 416 | 0.110 |
Why?
|
| Azo Compounds | 3 | 1982 | 113 | 0.110 |
Why?
|
| Organ Transplantation | 1 | 2023 | 1135 | 0.110 |
Why?
|
| Analysis of Variance | 4 | 2015 | 6365 | 0.110 |
Why?
|
| Gene Silencing | 1 | 2019 | 1538 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 3 | 2014 | 2699 | 0.110 |
Why?
|
| Eicosanoic Acids | 1 | 1992 | 15 | 0.110 |
Why?
|
| Anopheles | 1 | 2015 | 197 | 0.110 |
Why?
|
| Granulocytes | 4 | 1987 | 546 | 0.110 |
Why?
|
| Colitis, Ulcerative | 1 | 2005 | 1901 | 0.110 |
Why?
|
| Interleukin-10 | 4 | 2012 | 1200 | 0.110 |
Why?
|
| Eye Diseases | 1 | 2018 | 670 | 0.110 |
Why?
|
| Phospholipases | 3 | 2022 | 72 | 0.110 |
Why?
|
| Central Nervous System | 2 | 2018 | 1354 | 0.110 |
Why?
|
| Histamine H1 Antagonists | 1 | 2013 | 100 | 0.110 |
Why?
|
| Acetylation | 2 | 2006 | 1085 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 2 | 2015 | 1655 | 0.110 |
Why?
|
| Antimicrobial Cationic Peptides | 3 | 2011 | 362 | 0.110 |
Why?
|
| Carrageenan | 2 | 2015 | 66 | 0.110 |
Why?
|
| Brain Ischemia | 2 | 2020 | 3258 | 0.110 |
Why?
|
| Myeloid Cells | 1 | 2017 | 804 | 0.110 |
Why?
|
| Inflammasomes | 1 | 2017 | 493 | 0.110 |
Why?
|
| Carrier Proteins | 2 | 2017 | 5019 | 0.110 |
Why?
|
| Proteome | 2 | 2018 | 1790 | 0.110 |
Why?
|
| Triglycerides | 1 | 2020 | 2450 | 0.110 |
Why?
|
| Immunoglobulin G | 4 | 2014 | 4554 | 0.110 |
Why?
|
| X-Ray Microtomography | 1 | 2014 | 428 | 0.110 |
Why?
|
| Swine, Miniature | 1 | 2014 | 961 | 0.110 |
Why?
|
| Patch-Clamp Techniques | 2 | 2012 | 963 | 0.110 |
Why?
|
| Drug Stability | 3 | 2008 | 290 | 0.110 |
Why?
|
| Antibody-Producing Cells | 1 | 2012 | 143 | 0.110 |
Why?
|
| Actins | 2 | 2010 | 2120 | 0.110 |
Why?
|
| Ki-67 Antigen | 1 | 2014 | 644 | 0.110 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 1782 | 0.110 |
Why?
|
| Neointima | 1 | 2013 | 135 | 0.100 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2014 | 248 | 0.100 |
Why?
|
| Enzyme Induction | 2 | 2004 | 475 | 0.100 |
Why?
|
| Coenzyme A Ligases | 1 | 2012 | 43 | 0.100 |
Why?
|
| Zebrafish Proteins | 1 | 2018 | 1004 | 0.100 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2013 | 172 | 0.100 |
Why?
|
| Phylogeny | 3 | 2010 | 2797 | 0.100 |
Why?
|
| Cell Membrane | 7 | 2004 | 3744 | 0.100 |
Why?
|
| Immunohistochemistry | 8 | 2016 | 11363 | 0.100 |
Why?
|
| Tuberculosis, Meningeal | 1 | 2012 | 45 | 0.100 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2016 | 495 | 0.100 |
Why?
|
| Mycobacterium Infections | 1 | 2012 | 119 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2003 | 2837 | 0.100 |
Why?
|
| Liver | 5 | 2016 | 7470 | 0.100 |
Why?
|
| Pseudomonas Infections | 1 | 2015 | 608 | 0.100 |
Why?
|
| Fossils | 1 | 2011 | 76 | 0.100 |
Why?
|
| Bone Density | 1 | 2004 | 3469 | 0.100 |
Why?
|
| Pain, Postoperative | 2 | 2011 | 1638 | 0.100 |
Why?
|
| Proteins | 2 | 2010 | 6096 | 0.100 |
Why?
|
| Intestines | 2 | 2017 | 1923 | 0.100 |
Why?
|
| Transcription Factors | 3 | 2001 | 12164 | 0.100 |
Why?
|
| Colorectal Neoplasms | 2 | 2017 | 6754 | 0.100 |
Why?
|
| Antineoplastic Agents | 3 | 2019 | 13655 | 0.100 |
Why?
|
| Benchmarking | 1 | 2017 | 1038 | 0.100 |
Why?
|
| Oxidants | 1 | 2011 | 164 | 0.100 |
Why?
|
| Microbial Viability | 1 | 2012 | 234 | 0.100 |
Why?
|
| Peritoneum | 2 | 2020 | 226 | 0.100 |
Why?
|
| Cell Degranulation | 2 | 2003 | 287 | 0.090 |
Why?
|
| Microsomes | 2 | 2000 | 257 | 0.090 |
Why?
|
| Cell Nucleus | 7 | 2010 | 2968 | 0.090 |
Why?
|
| Hypothermia | 1 | 2012 | 189 | 0.090 |
Why?
|
| Mitochondria | 3 | 2020 | 3520 | 0.090 |
Why?
|
| Corneal Transplantation | 1 | 2014 | 368 | 0.090 |
Why?
|
| Amyloid beta-Peptides | 3 | 2015 | 3574 | 0.090 |
Why?
|
| Carbachol | 2 | 2022 | 226 | 0.090 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2014 | 457 | 0.090 |
Why?
|
| Lactosylceramides | 1 | 1990 | 15 | 0.090 |
Why?
|
| Indicators and Reagents | 3 | 2007 | 462 | 0.090 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 508 | 0.090 |
Why?
|
| Anemia, Sickle Cell | 1 | 2018 | 1017 | 0.090 |
Why?
|
| Trout | 2 | 2007 | 18 | 0.090 |
Why?
|
| Trihexosylceramides | 1 | 1990 | 32 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4200 | 0.090 |
Why?
|
| Cell Division | 3 | 2006 | 4564 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2001 | 3020 | 0.090 |
Why?
|
| Protein Kinase C | 5 | 2020 | 1227 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 3504 | 0.090 |
Why?
|
| Osteogenesis | 2 | 2014 | 1299 | 0.090 |
Why?
|
| Synovial Fluid | 1 | 2012 | 394 | 0.090 |
Why?
|
| Ovalbumin | 3 | 2018 | 719 | 0.090 |
Why?
|
| Immunity, Humoral | 1 | 2014 | 596 | 0.090 |
Why?
|
| Molecular Mimicry | 1 | 2011 | 201 | 0.090 |
Why?
|
| Microcirculation | 4 | 2003 | 1285 | 0.090 |
Why?
|
| Folic Acid | 1 | 2017 | 1300 | 0.090 |
Why?
|
| Preoperative Care | 1 | 2019 | 2245 | 0.090 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2021 | 173 | 0.090 |
Why?
|
| Pain Measurement | 4 | 2013 | 3418 | 0.090 |
Why?
|
| Pulmonary Emphysema | 1 | 2015 | 672 | 0.090 |
Why?
|
| Long-Term Potentiation | 1 | 2011 | 293 | 0.090 |
Why?
|
| Psoriasis | 1 | 2018 | 898 | 0.090 |
Why?
|
| Sciatic Nerve | 1 | 2013 | 609 | 0.090 |
Why?
|
| Receptor Cross-Talk | 2 | 2013 | 118 | 0.090 |
Why?
|
| Interleukin-4 | 3 | 1999 | 1146 | 0.090 |
Why?
|
| Aged | 17 | 2023 | 162944 | 0.090 |
Why?
|
| Vitamin D | 1 | 2023 | 3211 | 0.090 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2022 | 2099 | 0.090 |
Why?
|
| Receptors, Purinergic P2Y12 | 1 | 2010 | 132 | 0.090 |
Why?
|
| Biotransformation | 3 | 1997 | 168 | 0.090 |
Why?
|
| Lovastatin | 1 | 2010 | 120 | 0.090 |
Why?
|
| Aorta | 2 | 2016 | 2057 | 0.090 |
Why?
|
| Plants | 2 | 2002 | 314 | 0.090 |
Why?
|
| Glycosphingolipids | 1 | 1990 | 79 | 0.090 |
Why?
|
| Pharmacology, Clinical | 1 | 2009 | 20 | 0.090 |
Why?
|
| Epoprostenol | 2 | 1996 | 254 | 0.090 |
Why?
|
| Arteriosclerosis | 2 | 2004 | 1092 | 0.090 |
Why?
|
| Microfilament Proteins | 3 | 2021 | 1152 | 0.090 |
Why?
|
| Temporomandibular Joint | 1 | 2011 | 196 | 0.090 |
Why?
|
| Interleukin-2 | 1 | 2016 | 1887 | 0.090 |
Why?
|
| Biological Transport | 3 | 2000 | 2119 | 0.090 |
Why?
|
| Transcription, Genetic | 6 | 2013 | 7721 | 0.090 |
Why?
|
| Dextran Sulfate | 1 | 2010 | 236 | 0.090 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2008 | 50 | 0.090 |
Why?
|
| Melanoma, Experimental | 2 | 2017 | 559 | 0.090 |
Why?
|
| Cell Line, Tumor | 7 | 2021 | 16665 | 0.090 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2010 | 152 | 0.090 |
Why?
|
| Glycolipids | 1 | 1990 | 205 | 0.080 |
Why?
|
| Rats, Wistar | 6 | 2008 | 1902 | 0.080 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2011 | 370 | 0.080 |
Why?
|
| Smoking | 3 | 2015 | 8969 | 0.080 |
Why?
|
| Oncorhynchus mykiss | 3 | 2005 | 24 | 0.080 |
Why?
|
| N-Formylmethionine | 3 | 1983 | 16 | 0.080 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2010 | 174 | 0.080 |
Why?
|
| Hematopoiesis | 1 | 2018 | 2066 | 0.080 |
Why?
|
| Receptors, Prostaglandin E | 1 | 2008 | 56 | 0.080 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2012 | 475 | 0.080 |
Why?
|
| Sequence Alignment | 3 | 2005 | 2257 | 0.080 |
Why?
|
| Sphingolipids | 1 | 1990 | 159 | 0.080 |
Why?
|
| Vancomycin | 1 | 2012 | 500 | 0.080 |
Why?
|
| Young Adult | 9 | 2019 | 56350 | 0.080 |
Why?
|
| Oleic Acid | 1 | 2008 | 85 | 0.080 |
Why?
|
| Ion Channels | 3 | 2023 | 1056 | 0.080 |
Why?
|
| Edetic Acid | 1 | 2008 | 277 | 0.080 |
Why?
|
| Ear | 2 | 1999 | 173 | 0.080 |
Why?
|
| Brain Injuries | 1 | 2020 | 2024 | 0.080 |
Why?
|
| Immunity, Active | 1 | 2008 | 60 | 0.080 |
Why?
|
| Oxidation-Reduction | 6 | 1996 | 2187 | 0.080 |
Why?
|
| Multiple Sclerosis | 2 | 2021 | 3076 | 0.080 |
Why?
|
| Tumor Microenvironment | 3 | 2020 | 3564 | 0.080 |
Why?
|
| Fatty Acids, Omega-6 | 2 | 2007 | 227 | 0.080 |
Why?
|
| Umbilical Veins | 4 | 2000 | 433 | 0.080 |
Why?
|
| Leukocyte Rolling | 1 | 2008 | 72 | 0.080 |
Why?
|
| Cytosol | 4 | 2003 | 901 | 0.080 |
Why?
|
| Interleukin-13 | 2 | 2002 | 389 | 0.080 |
Why?
|
| Thromboxane A2 | 2 | 2007 | 92 | 0.080 |
Why?
|
| Microspheres | 1 | 2011 | 777 | 0.080 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2008 | 55 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 1912 | 0.080 |
Why?
|
| Respiratory Insufficiency | 1 | 2017 | 1199 | 0.080 |
Why?
|
| Uric Acid | 2 | 1984 | 760 | 0.080 |
Why?
|
| Immunity, Mucosal | 1 | 2011 | 491 | 0.080 |
Why?
|
| Acetaminophen | 2 | 2003 | 544 | 0.080 |
Why?
|
| Venules | 1 | 2008 | 163 | 0.080 |
Why?
|
| Immunity | 1 | 2014 | 1011 | 0.080 |
Why?
|
| Electric Impedance | 1 | 2012 | 727 | 0.080 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2011 | 561 | 0.080 |
Why?
|
| Antiviral Agents | 1 | 2020 | 2978 | 0.080 |
Why?
|
| Cyclosporine | 1 | 2010 | 784 | 0.080 |
Why?
|
| Megakaryocytes | 1 | 1992 | 542 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 2 | 2021 | 1081 | 0.080 |
Why?
|
| Sphingosine | 1 | 1990 | 307 | 0.080 |
Why?
|
| Interferon-gamma | 4 | 2008 | 3199 | 0.080 |
Why?
|
| Intramolecular Oxidoreductases | 2 | 2008 | 109 | 0.080 |
Why?
|
| Case-Control Studies | 5 | 2018 | 21719 | 0.080 |
Why?
|
| Phenyl Ethers | 1 | 2007 | 58 | 0.080 |
Why?
|
| Hemorrhage | 1 | 2019 | 3461 | 0.080 |
Why?
|
| Integrins | 1 | 2012 | 845 | 0.080 |
Why?
|
| Lipid Peroxides | 6 | 1987 | 73 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2008 | 534 | 0.070 |
Why?
|
| Corneal Neovascularization | 1 | 2009 | 188 | 0.070 |
Why?
|
| Lung Diseases | 2 | 2004 | 1884 | 0.070 |
Why?
|
| Diabetes Complications | 1 | 2014 | 1359 | 0.070 |
Why?
|
| Hippocampus | 4 | 2014 | 3661 | 0.070 |
Why?
|
| Deuterium | 1 | 2007 | 101 | 0.070 |
Why?
|
| Immunologic Memory | 1 | 2014 | 1348 | 0.070 |
Why?
|
| Chromatography, Gas | 1 | 2007 | 156 | 0.070 |
Why?
|
| Prostaglandins B | 2 | 1990 | 5 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 3444 | 0.070 |
Why?
|
| Phenylpropionates | 1 | 2006 | 30 | 0.070 |
Why?
|
| Heart Failure | 3 | 2020 | 10856 | 0.070 |
Why?
|
| Liver Diseases | 1 | 2015 | 1252 | 0.070 |
Why?
|
| Blood Gas Analysis | 2 | 2018 | 381 | 0.070 |
Why?
|
| Culture Media | 1 | 2008 | 902 | 0.070 |
Why?
|
| Flavonoids | 1 | 2009 | 443 | 0.070 |
Why?
|
| Respiratory Mucosa | 1 | 2010 | 427 | 0.070 |
Why?
|
| Cloning, Molecular | 3 | 1998 | 4322 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 3920 | 0.070 |
Why?
|
| Fish Proteins | 1 | 2006 | 46 | 0.070 |
Why?
|
| Fatty Acid Desaturases | 1 | 2006 | 102 | 0.070 |
Why?
|
| Complement Inactivating Agents | 1 | 2006 | 50 | 0.070 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2006 | 49 | 0.070 |
Why?
|
| Peroxides | 1 | 2006 | 74 | 0.070 |
Why?
|
| Adenoma | 1 | 2017 | 2168 | 0.070 |
Why?
|
| Molecular Conformation | 2 | 2006 | 563 | 0.070 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2016 | 1625 | 0.070 |
Why?
|
| Carbon Radioisotopes | 3 | 2013 | 592 | 0.070 |
Why?
|
| Surgical Flaps | 1 | 2014 | 1634 | 0.070 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2012 | 828 | 0.070 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2009 | 2038 | 0.070 |
Why?
|
| Microfluidics | 1 | 2011 | 662 | 0.070 |
Why?
|
| Ovariectomy | 1 | 2008 | 660 | 0.070 |
Why?
|
| Brain Chemistry | 2 | 2007 | 981 | 0.070 |
Why?
|
| Serum Albumin | 1 | 2008 | 674 | 0.070 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2007 | 274 | 0.070 |
Why?
|
| Host vs Graft Reaction | 1 | 2005 | 14 | 0.070 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2005 | 55 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2015 | 3038 | 0.070 |
Why?
|
| Parkinson Disease | 1 | 2019 | 2774 | 0.070 |
Why?
|
| Cell Lineage | 1 | 2014 | 2504 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 2 | 2005 | 916 | 0.060 |
Why?
|
| DNA Fragmentation | 2 | 2004 | 242 | 0.060 |
Why?
|
| Protein Multimerization | 1 | 2010 | 971 | 0.060 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2006 | 176 | 0.060 |
Why?
|
| Virulence Factors, Bordetella | 2 | 1998 | 156 | 0.060 |
Why?
|
| Ions | 2 | 2004 | 264 | 0.060 |
Why?
|
| Pertussis Toxin | 2 | 1998 | 178 | 0.060 |
Why?
|
| Aged, 80 and over | 6 | 2017 | 57683 | 0.060 |
Why?
|
| Platelet Aggregation | 1 | 2008 | 800 | 0.060 |
Why?
|
| Cell Survival | 6 | 2015 | 5872 | 0.060 |
Why?
|
| Metabolism | 1 | 2006 | 193 | 0.060 |
Why?
|
| Peptide Fragments | 2 | 2015 | 5095 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 1999 | 1213 | 0.060 |
Why?
|
| Sarcoidosis | 1 | 1990 | 503 | 0.060 |
Why?
|
| Calgranulin B | 1 | 2005 | 84 | 0.060 |
Why?
|
| Time Factors | 8 | 2008 | 40054 | 0.060 |
Why?
|
| Candida albicans | 1 | 2007 | 394 | 0.060 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 1992 | 1873 | 0.060 |
Why?
|
| Interleukin-5 | 2 | 2002 | 273 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 5163 | 0.060 |
Why?
|
| Protein Binding | 4 | 2015 | 9387 | 0.060 |
Why?
|
| Bone Resorption | 1 | 2008 | 722 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2020 | 1989 | 0.060 |
Why?
|
| Injections, Intravenous | 2 | 2004 | 1420 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 643 | 0.060 |
Why?
|
| Bacteroidaceae Infections | 2 | 2003 | 32 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 2 | 2007 | 2633 | 0.060 |
Why?
|
| Cytochalasin B | 2 | 2000 | 74 | 0.060 |
Why?
|
| Adjuvants, Immunologic | 2 | 2014 | 1000 | 0.060 |
Why?
|
| Alkenes | 1 | 1984 | 57 | 0.060 |
Why?
|
| Contractile Proteins | 1 | 2005 | 246 | 0.060 |
Why?
|
| Graft Survival | 2 | 2014 | 3733 | 0.060 |
Why?
|
| Vasculitis | 1 | 2008 | 521 | 0.060 |
Why?
|
| 3T3 Cells | 2 | 2003 | 1101 | 0.060 |
Why?
|
| beta-Adrenergic Receptor Kinases | 1 | 2023 | 9 | 0.060 |
Why?
|
| Depression, Chemical | 2 | 2001 | 191 | 0.060 |
Why?
|
| Haptoglobins | 1 | 2005 | 165 | 0.060 |
Why?
|
| Remission Induction | 1 | 2009 | 2384 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 2842 | 0.060 |
Why?
|
| Drug Interactions | 2 | 2001 | 1458 | 0.060 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2004 | 220 | 0.060 |
Why?
|
| Coronary Disease | 2 | 2016 | 6078 | 0.060 |
Why?
|
| Behavior, Animal | 1 | 2012 | 1882 | 0.060 |
Why?
|
| Automation | 1 | 2006 | 584 | 0.060 |
Why?
|
| Injections, Intraperitoneal | 2 | 2021 | 424 | 0.060 |
Why?
|
| Animals, Newborn | 2 | 2020 | 2723 | 0.060 |
Why?
|
| Internationality | 1 | 2009 | 1002 | 0.060 |
Why?
|
| Butadienes | 1 | 2003 | 110 | 0.060 |
Why?
|
| Skin Diseases | 1 | 2012 | 1065 | 0.060 |
Why?
|
| Chemical Phenomena | 4 | 1989 | 517 | 0.060 |
Why?
|
| Pleurisy | 2 | 2000 | 53 | 0.060 |
Why?
|
| Neuronal Plasticity | 1 | 2011 | 1418 | 0.060 |
Why?
|
| Pancreatic Elastase | 3 | 2012 | 135 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2013 | 3760 | 0.060 |
Why?
|
| Pre-Eclampsia | 1 | 2012 | 1196 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2019 | 2502 | 0.060 |
Why?
|
| Cell Death | 1 | 2008 | 1695 | 0.060 |
Why?
|
| Caseins | 1 | 2003 | 103 | 0.060 |
Why?
|
| Immune Sera | 1 | 2003 | 641 | 0.060 |
Why?
|
| Peroxynitrous Acid | 1 | 2002 | 41 | 0.060 |
Why?
|
| Phorbols | 1 | 1982 | 43 | 0.050 |
Why?
|
| Protein Conformation | 3 | 2004 | 4013 | 0.050 |
Why?
|
| Disease Progression | 1 | 2019 | 13256 | 0.050 |
Why?
|
| Receptors, Cannabinoid | 1 | 2022 | 44 | 0.050 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2015 | 1210 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2007 | 1675 | 0.050 |
Why?
|
| Chemokine CCL11 | 1 | 2002 | 129 | 0.050 |
Why?
|
| Carboxylic Acids | 1 | 2003 | 99 | 0.050 |
Why?
|
| Anions | 2 | 2000 | 133 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 4823 | 0.050 |
Why?
|
| Scavenger Receptors, Class E | 1 | 2022 | 8 | 0.050 |
Why?
|
| Immunomodulation | 2 | 2018 | 540 | 0.050 |
Why?
|
| Anticholesteremic Agents | 1 | 2010 | 979 | 0.050 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2016 | 507 | 0.050 |
Why?
|
| Toxoplasmosis | 1 | 2002 | 91 | 0.050 |
Why?
|
| Methacholine Chloride | 1 | 2002 | 233 | 0.050 |
Why?
|
| Apolipoproteins E | 3 | 2016 | 1438 | 0.050 |
Why?
|
| Niflumic Acid | 1 | 2001 | 10 | 0.050 |
Why?
|
| Lipid Peroxidation | 3 | 2012 | 270 | 0.050 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2017 | 2410 | 0.050 |
Why?
|
| Sirolimus | 1 | 2009 | 1562 | 0.050 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2012 | 1181 | 0.050 |
Why?
|
| Chemistry | 3 | 1989 | 352 | 0.050 |
Why?
|
| Dihydrotestosterone | 1 | 2022 | 188 | 0.050 |
Why?
|
| Chromatin | 2 | 2006 | 2917 | 0.050 |
Why?
|
| Teichoic Acids | 1 | 2022 | 66 | 0.050 |
Why?
|
| Dactinomycin | 2 | 1993 | 317 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2012 | 2575 | 0.050 |
Why?
|
| Lung Transplantation | 1 | 2010 | 1155 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2007 | 1158 | 0.050 |
Why?
|
| Antioxidants | 1 | 2010 | 1659 | 0.050 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2018 | 261 | 0.050 |
Why?
|
| Retinal Vessels | 1 | 2007 | 769 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2016 | 11695 | 0.050 |
Why?
|
| Estrogen Receptor beta | 1 | 2022 | 175 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2008 | 1333 | 0.050 |
Why?
|
| Jurkat Cells | 1 | 2003 | 742 | 0.050 |
Why?
|
| Estrone | 1 | 2022 | 239 | 0.050 |
Why?
|
| Neuroblastoma | 1 | 2009 | 1225 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 2 | 2012 | 2763 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2005 | 960 | 0.050 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2004 | 386 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2018 | 489 | 0.050 |
Why?
|
| Diclofenac | 1 | 2001 | 71 | 0.050 |
Why?
|
| Caco-2 Cells | 2 | 2002 | 387 | 0.050 |
Why?
|
| Chemokines, CC | 1 | 2002 | 291 | 0.050 |
Why?
|
| Brugia | 2 | 1991 | 24 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 2940 | 0.050 |
Why?
|
| Injections, Intradermal | 1 | 2001 | 117 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 4029 | 0.050 |
Why?
|
| Software | 2 | 2006 | 4434 | 0.050 |
Why?
|
| Transgenes | 1 | 2004 | 1009 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2014 | 2986 | 0.050 |
Why?
|
| Placebos | 1 | 2005 | 1677 | 0.050 |
Why?
|
| Pleural Effusion | 2 | 2001 | 338 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9185 | 0.050 |
Why?
|
| Streptozocin | 1 | 2021 | 193 | 0.050 |
Why?
|
| Bone Remodeling | 1 | 2004 | 575 | 0.050 |
Why?
|
| Kidney | 5 | 2015 | 7167 | 0.050 |
Why?
|
| Coronary Vessels | 1 | 1992 | 3099 | 0.050 |
Why?
|
| Umbilical Cord | 1 | 2002 | 180 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2009 | 2128 | 0.050 |
Why?
|
| Receptors, Opioid | 1 | 2001 | 155 | 0.050 |
Why?
|
| Angiostrongylus | 1 | 2000 | 2 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 4664 | 0.050 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2020 | 130 | 0.050 |
Why?
|
| Respiratory Burst | 1 | 2000 | 113 | 0.050 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2022 | 206 | 0.050 |
Why?
|
| Double-Blind Method | 3 | 2023 | 12017 | 0.050 |
Why?
|
| Emulsions | 1 | 2020 | 155 | 0.050 |
Why?
|
| Chemokine CCL4 | 1 | 2000 | 128 | 0.050 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2003 | 365 | 0.050 |
Why?
|
| Adoptive Transfer | 2 | 2014 | 844 | 0.050 |
Why?
|
| Renal Circulation | 2 | 1992 | 333 | 0.050 |
Why?
|
| Explosions | 1 | 2021 | 109 | 0.050 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2000 | 122 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2002 | 772 | 0.050 |
Why?
|
| Ventricular Remodeling | 2 | 2020 | 1224 | 0.050 |
Why?
|
| Th1 Cells | 2 | 2021 | 1056 | 0.050 |
Why?
|
| Cell Fractionation | 1 | 2000 | 252 | 0.050 |
Why?
|
| Caspase 3 | 3 | 2009 | 759 | 0.050 |
Why?
|
| Gingival Crevicular Fluid | 1 | 2000 | 92 | 0.050 |
Why?
|
| 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | 3 | 2011 | 16 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2022 | 491 | 0.050 |
Why?
|
| Guinea Pigs | 4 | 1989 | 1386 | 0.050 |
Why?
|
| Administration, Intranasal | 1 | 2021 | 446 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2012 | 3502 | 0.050 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2012 | 3695 | 0.050 |
Why?
|
| Intracellular Space | 1 | 2021 | 212 | 0.040 |
Why?
|
| Lectins | 1 | 2022 | 514 | 0.040 |
Why?
|
| Strongylida Infections | 1 | 2000 | 46 | 0.040 |
Why?
|
| Salmonella typhimurium | 2 | 2002 | 351 | 0.040 |
Why?
|
| Linoleic Acid | 1 | 2021 | 157 | 0.040 |
Why?
|
| Methionine | 1 | 1982 | 590 | 0.040 |
Why?
|
| Injections, Spinal | 2 | 2011 | 303 | 0.040 |
Why?
|
| Rats, Transgenic | 1 | 2019 | 71 | 0.040 |
Why?
|
| Killer Cells, Natural | 5 | 1987 | 2133 | 0.040 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2006 | 849 | 0.040 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2000 | 370 | 0.040 |
Why?
|
| Horses | 1 | 2000 | 304 | 0.040 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 2019 | 76 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2003 | 1202 | 0.040 |
Why?
|
| Plasminogen Inactivators | 1 | 2019 | 38 | 0.040 |
Why?
|
| Adolescent | 5 | 2018 | 85649 | 0.040 |
Why?
|
| Peripheral Arterial Disease | 1 | 2010 | 1184 | 0.040 |
Why?
|
| Brassica | 1 | 1999 | 38 | 0.040 |
Why?
|
| Prostaglandin Antagonists | 1 | 2019 | 30 | 0.040 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2020 | 295 | 0.040 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2000 | 226 | 0.040 |
Why?
|
| Alzheimer Disease | 2 | 2014 | 7988 | 0.040 |
Why?
|
| Endothelial Growth Factors | 1 | 2002 | 694 | 0.040 |
Why?
|
| Protein Transport | 3 | 2014 | 1988 | 0.040 |
Why?
|
| Interleukins | 2 | 2018 | 791 | 0.040 |
Why?
|
| Immunoglobulin M | 2 | 2014 | 1538 | 0.040 |
Why?
|
| Sex Factors | 2 | 2020 | 10392 | 0.040 |
Why?
|
| src Homology Domains | 1 | 2000 | 364 | 0.040 |
Why?
|
| Protozoan Proteins | 1 | 2005 | 827 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2004 | 3770 | 0.040 |
Why?
|
| Cell Count | 2 | 2015 | 1831 | 0.040 |
Why?
|
| Administration, Oral | 2 | 2004 | 3913 | 0.040 |
Why?
|
| Carboxyhemoglobin | 1 | 2018 | 81 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2000 | 1086 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2020 | 2751 | 0.040 |
Why?
|
| Quantum Theory | 1 | 2018 | 70 | 0.040 |
Why?
|
| Cholinergic Agonists | 1 | 2018 | 74 | 0.040 |
Why?
|
| Biology | 1 | 2021 | 292 | 0.040 |
Why?
|
| Phenotype | 4 | 2023 | 16331 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 1996 | 6347 | 0.040 |
Why?
|
| COS Cells | 1 | 2001 | 1160 | 0.040 |
Why?
|
| Lymphokines | 1 | 2002 | 949 | 0.040 |
Why?
|
| Cholecalciferol | 1 | 2023 | 537 | 0.040 |
Why?
|
| Skin Physiological Phenomena | 1 | 1999 | 180 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2006 | 2739 | 0.040 |
Why?
|
| Brain Infarction | 1 | 2020 | 296 | 0.040 |
Why?
|
| Radioactive Tracers | 1 | 2018 | 73 | 0.040 |
Why?
|
| Neoplasm Metastasis | 2 | 2019 | 4839 | 0.040 |
Why?
|
| Estrogen Receptor alpha | 1 | 2022 | 577 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 2 | 2019 | 4465 | 0.040 |
Why?
|
| Ear Diseases | 1 | 2000 | 169 | 0.040 |
Why?
|
| Nitriles | 1 | 2003 | 952 | 0.040 |
Why?
|
| Carcinogens | 1 | 2020 | 466 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 1999 | 791 | 0.040 |
Why?
|
| Receptors, Cytokine | 1 | 1999 | 261 | 0.040 |
Why?
|
| Gene Expression Profiling | 3 | 2016 | 9410 | 0.040 |
Why?
|
| Blister | 1 | 2018 | 85 | 0.040 |
Why?
|
| Plasmids | 1 | 2003 | 2305 | 0.040 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2017 | 83 | 0.040 |
Why?
|
| Substantia Nigra | 1 | 2019 | 353 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 8925 | 0.040 |
Why?
|
| Chromosome Inversion | 1 | 1998 | 127 | 0.040 |
Why?
|
| Hindlimb | 1 | 1999 | 505 | 0.040 |
Why?
|
| alpha-Synuclein | 2 | 2019 | 724 | 0.040 |
Why?
|
| Splanchnic Circulation | 1 | 1997 | 110 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2020 | 675 | 0.040 |
Why?
|
| Subcellular Fractions | 2 | 2002 | 547 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 3 | 2012 | 5867 | 0.040 |
Why?
|
| International Agencies | 2 | 2011 | 240 | 0.040 |
Why?
|
| Sheep | 2 | 2006 | 1437 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2018 | 480 | 0.040 |
Why?
|
| Heart Transplantation | 1 | 2010 | 3119 | 0.040 |
Why?
|
| Bacterial Load | 1 | 2017 | 153 | 0.040 |
Why?
|
| Hydroxy Acids | 2 | 2008 | 18 | 0.040 |
Why?
|
| Prednisolone | 1 | 2018 | 333 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 2 | 2010 | 1799 | 0.040 |
Why?
|
| Discriminant Analysis | 1 | 2017 | 235 | 0.040 |
Why?
|
| Hydrogen Peroxide | 2 | 2010 | 730 | 0.040 |
Why?
|
| Thiazolidinediones | 1 | 2000 | 476 | 0.040 |
Why?
|
| Phosphatidylserines | 1 | 2017 | 192 | 0.040 |
Why?
|
| Receptors, Leukocyte-Adhesion | 2 | 1994 | 53 | 0.040 |
Why?
|
| Guanosine Triphosphate | 1 | 1997 | 321 | 0.040 |
Why?
|
| Mesentery | 1 | 2017 | 205 | 0.030 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2022 | 923 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 1875 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2019 | 617 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2022 | 1179 | 0.030 |
Why?
|
| Endothelium | 1 | 1999 | 778 | 0.030 |
Why?
|
| Dopamine | 1 | 2003 | 1589 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 2022 | 1057 | 0.030 |
Why?
|
| Partial Thromboplastin Time | 1 | 2017 | 206 | 0.030 |
Why?
|
| Free Radicals | 2 | 1989 | 236 | 0.030 |
Why?
|
| Age Factors | 2 | 2019 | 18355 | 0.030 |
Why?
|
| Periodontal Diseases | 1 | 1999 | 449 | 0.030 |
Why?
|
| Muscle Stretching Exercises | 1 | 2015 | 33 | 0.030 |
Why?
|
| Atrophy | 1 | 2020 | 1576 | 0.030 |
Why?
|
| Host-Parasite Interactions | 1 | 2018 | 294 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 1992 | 9274 | 0.030 |
Why?
|
| Postmortem Changes | 1 | 2015 | 125 | 0.030 |
Why?
|
| Muscle, Smooth | 3 | 1989 | 933 | 0.030 |
Why?
|
| Bicarbonates | 1 | 2017 | 313 | 0.030 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2021 | 834 | 0.030 |
Why?
|
| Immune Complex Diseases | 1 | 1995 | 54 | 0.030 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2018 | 269 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2000 | 692 | 0.030 |
Why?
|
| Carboxypeptidases | 1 | 1995 | 176 | 0.030 |
Why?
|
| Alprostadil | 2 | 1993 | 89 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2010 | 4246 | 0.030 |
Why?
|
| Interleukin-1beta | 2 | 2013 | 972 | 0.030 |
Why?
|
| Societies, Scientific | 1 | 2016 | 220 | 0.030 |
Why?
|
| Vitamins | 1 | 2023 | 1608 | 0.030 |
Why?
|
| Hydrochloric Acid | 1 | 2014 | 76 | 0.030 |
Why?
|
| Estradiol | 1 | 2022 | 2021 | 0.030 |
Why?
|
| Bilirubin | 1 | 2017 | 424 | 0.030 |
Why?
|
| Glasgow Coma Scale | 1 | 2017 | 570 | 0.030 |
Why?
|
| Chemokine CCL3 | 1 | 2014 | 83 | 0.030 |
Why?
|
| Ovary | 1 | 2019 | 981 | 0.030 |
Why?
|
| Staurosporine | 1 | 2015 | 251 | 0.030 |
Why?
|
| Toll-Like Receptors | 2 | 2010 | 592 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2021 | 765 | 0.030 |
Why?
|
| Monoacylglycerol Lipases | 1 | 2015 | 48 | 0.030 |
Why?
|
| Cell Polarity | 2 | 2015 | 644 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2000 | 1640 | 0.030 |
Why?
|
| Guanylyl Imidodiphosphate | 1 | 1994 | 36 | 0.030 |
Why?
|
| Ketoconazole | 1 | 1994 | 95 | 0.030 |
Why?
|
| Neurodegenerative Diseases | 1 | 2003 | 1060 | 0.030 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2011 | 449 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2022 | 2186 | 0.030 |
Why?
|
| Haplotypes | 1 | 2021 | 2781 | 0.030 |
Why?
|
| Entorhinal Cortex | 1 | 2015 | 264 | 0.030 |
Why?
|
| Dimethyl Sulfoxide | 2 | 1993 | 249 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2017 | 40955 | 0.030 |
Why?
|
| Receptors, Aryl Hydrocarbon | 2 | 2006 | 209 | 0.030 |
Why?
|
| Zebrafish | 2 | 2018 | 2990 | 0.030 |
Why?
|
| Amidohydrolases | 1 | 2015 | 169 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 3 | 1987 | 1368 | 0.030 |
Why?
|
| Smoke | 1 | 2015 | 226 | 0.030 |
Why?
|
| Pregnancy | 3 | 2016 | 29087 | 0.030 |
Why?
|
| Reference Standards | 1 | 2017 | 1020 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 1086 | 0.030 |
Why?
|
| Connective Tissue | 1 | 2015 | 420 | 0.030 |
Why?
|
| Receptors, Histamine H1 | 1 | 2013 | 18 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2018 | 814 | 0.030 |
Why?
|
| Ibuprofen | 2 | 1999 | 235 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1995 | 433 | 0.030 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2014 | 157 | 0.030 |
Why?
|
| Injections, Intraventricular | 1 | 2013 | 230 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2018 | 1539 | 0.030 |
Why?
|
| Cisplatin | 1 | 2019 | 1637 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 1015 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 2017 | 643 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2014 | 286 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 5724 | 0.030 |
Why?
|
| Homozygote | 1 | 1998 | 1777 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2002 | 1911 | 0.030 |
Why?
|
| Iloprost | 1 | 1992 | 29 | 0.030 |
Why?
|
| Methionine Sulfoximine | 1 | 1992 | 12 | 0.030 |
Why?
|
| Buthionine Sulfoximine | 1 | 1992 | 18 | 0.030 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2013 | 156 | 0.030 |
Why?
|
| Eye Proteins | 1 | 2016 | 644 | 0.030 |
Why?
|
| Histidine | 1 | 1993 | 313 | 0.030 |
Why?
|
| Intensive Care Units | 2 | 2017 | 3679 | 0.030 |
Why?
|
| Metagenomics | 1 | 2016 | 430 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2017 | 8297 | 0.030 |
Why?
|
| Bone Marrow Cells | 2 | 2014 | 2513 | 0.030 |
Why?
|
| Medicine | 1 | 2021 | 941 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 1994 | 533 | 0.030 |
Why?
|
| Sputum | 1 | 2014 | 474 | 0.030 |
Why?
|
| Viral Load | 1 | 2021 | 3292 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2021 | 2899 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2020 | 1895 | 0.030 |
Why?
|
| Mycobacterium marinum | 1 | 2012 | 26 | 0.030 |
Why?
|
| Osteoprotegerin | 1 | 2012 | 176 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 2006 | 1802 | 0.030 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2011 | 58 | 0.030 |
Why?
|
| Cardiomegaly | 1 | 2015 | 619 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 708 | 0.030 |
Why?
|
| Pulmonary Edema | 1 | 2015 | 415 | 0.030 |
Why?
|
| Caspases | 2 | 2006 | 928 | 0.030 |
Why?
|
| Body Fluids | 1 | 1993 | 319 | 0.030 |
Why?
|
| Rectum | 1 | 2017 | 903 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 1996 | 13019 | 0.030 |
Why?
|
| Nutrition Policy | 1 | 2016 | 488 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2005 | 6191 | 0.030 |
Why?
|
| Transplantation, Homologous | 2 | 2014 | 4771 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 1995 | 668 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2017 | 1905 | 0.030 |
Why?
|
| Freund's Adjuvant | 1 | 2011 | 139 | 0.030 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2013 | 402 | 0.030 |
Why?
|
| Fatty Liver | 1 | 2017 | 728 | 0.020 |
Why?
|
| Platelet Transfusion | 1 | 2014 | 314 | 0.020 |
Why?
|
| Esterification | 1 | 1991 | 36 | 0.020 |
Why?
|
| Observer Variation | 1 | 2017 | 2593 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 1997 | 2030 | 0.020 |
Why?
|
| Plasma Cells | 1 | 2014 | 592 | 0.020 |
Why?
|
| Cytoplasmic Granules | 1 | 1994 | 610 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 1991 | 326 | 0.020 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2011 | 60 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 1998 | 14720 | 0.020 |
Why?
|
| Acylation | 1 | 1991 | 107 | 0.020 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1990 | 70 | 0.020 |
Why?
|
| International Cooperation | 1 | 2017 | 1421 | 0.020 |
Why?
|
| Cattle | 1 | 1997 | 3923 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2016 | 1961 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 1915 | 0.020 |
Why?
|
| Cerebrosides | 1 | 1990 | 7 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2011 | 264 | 0.020 |
Why?
|
| RNA | 1 | 2001 | 2747 | 0.020 |
Why?
|
| Globosides | 1 | 1990 | 13 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 1992 | 590 | 0.020 |
Why?
|
| Psychosine | 1 | 1990 | 8 | 0.020 |
Why?
|
| Cycloheximide | 1 | 1990 | 347 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 62966 | 0.020 |
Why?
|
| Diarrhea | 1 | 2017 | 1343 | 0.020 |
Why?
|
| Tretinoin | 1 | 1993 | 516 | 0.020 |
Why?
|
| Oxygen | 2 | 2002 | 4169 | 0.020 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2010 | 180 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2011 | 377 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 1992 | 405 | 0.020 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2010 | 62 | 0.020 |
Why?
|
| Genomics | 1 | 2006 | 5692 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2013 | 40450 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2012 | 792 | 0.020 |
Why?
|
| Acrylamides | 1 | 2011 | 252 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2014 | 1402 | 0.020 |
Why?
|
| Galactosylceramides | 1 | 1990 | 92 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1994 | 2552 | 0.020 |
Why?
|
| Posterior Horn Cells | 1 | 2010 | 87 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2020 | 2924 | 0.020 |
Why?
|
| Anticarcinogenic Agents | 1 | 2011 | 253 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1990 | 918 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3557 | 0.020 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 1 | 1989 | 83 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 2012 | 475 | 0.020 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1989 | 114 | 0.020 |
Why?
|
| Benzofurans | 1 | 1990 | 140 | 0.020 |
Why?
|
| Dicarboxylic Acids | 1 | 1989 | 70 | 0.020 |
Why?
|
| Inositol Phosphates | 1 | 1989 | 180 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 9941 | 0.020 |
Why?
|
| Receptors, Prostaglandin E, EP2 Subtype | 1 | 2008 | 40 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2011 | 595 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2009 | 126 | 0.020 |
Why?
|
| Dentin | 1 | 2008 | 73 | 0.020 |
Why?
|
| Colon | 1 | 2017 | 1773 | 0.020 |
Why?
|
| Femoral Artery | 1 | 2013 | 843 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2009 | 428 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 1998 | 1860 | 0.020 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2008 | 59 | 0.020 |
Why?
|
| Airway Resistance | 1 | 1989 | 404 | 0.020 |
Why?
|
| Half-Life | 1 | 1989 | 658 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2010 | 625 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2005 | 1434 | 0.020 |
Why?
|
| Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 2007 | 9 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1990 | 689 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 19862 | 0.020 |
Why?
|
| Models, Genetic | 1 | 1998 | 3493 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2020 | 3656 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 1727 | 0.020 |
Why?
|
| Phosphatidylcholines | 1 | 1989 | 411 | 0.020 |
Why?
|
| Antigens, Plant | 1 | 2007 | 86 | 0.020 |
Why?
|
| Saphenous Vein | 1 | 2010 | 531 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 1740 | 0.020 |
Why?
|
| Autophagy | 1 | 2015 | 1301 | 0.020 |
Why?
|
| Interleukin-6 | 2 | 2009 | 3199 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 1350 | 0.020 |
Why?
|
| Osteoblasts | 1 | 2012 | 1163 | 0.020 |
Why?
|
| Pain Threshold | 1 | 2011 | 585 | 0.020 |
Why?
|
| Interleukin-23 | 1 | 2008 | 193 | 0.020 |
Why?
|
| Nanotechnology | 1 | 2012 | 709 | 0.020 |
Why?
|
| Heart | 1 | 2020 | 4462 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2012 | 1839 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2011 | 849 | 0.020 |
Why?
|
| Prevalence | 1 | 2023 | 15194 | 0.020 |
Why?
|
| Body Weight | 1 | 2017 | 4664 | 0.020 |
Why?
|
| Cyclin D | 1 | 2006 | 71 | 0.020 |
Why?
|
| Sulfides | 1 | 2007 | 166 | 0.020 |
Why?
|
| Arterioles | 1 | 1987 | 253 | 0.020 |
Why?
|
| Collagen | 1 | 2015 | 2684 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2007 | 140 | 0.020 |
Why?
|
| Antitubercular Agents | 1 | 2014 | 1319 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 544 | 0.020 |
Why?
|
| Albumins | 1 | 1989 | 568 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 1683 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2007 | 297 | 0.020 |
Why?
|
| Weight Gain | 1 | 2016 | 2282 | 0.020 |
Why?
|
| Acetates | 1 | 2007 | 312 | 0.020 |
Why?
|
| Cyclopropanes | 1 | 2007 | 416 | 0.020 |
Why?
|
| p21-Activated Kinases | 1 | 2006 | 128 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2017 | 2566 | 0.020 |
Why?
|
| Biological Transport, Active | 2 | 1983 | 349 | 0.020 |
Why?
|
| Recurrence | 1 | 2017 | 8333 | 0.020 |
Why?
|
| Muscle Contraction | 2 | 1988 | 1241 | 0.020 |
Why?
|
| Antibodies | 1 | 2014 | 2459 | 0.020 |
Why?
|
| Linoleic Acids, Conjugated | 1 | 1985 | 14 | 0.020 |
Why?
|
| Receptors, Growth Factor | 1 | 2006 | 334 | 0.020 |
Why?
|
| Glucose | 1 | 2017 | 4391 | 0.020 |
Why?
|
| Profilins | 1 | 2005 | 66 | 0.020 |
Why?
|
| Pharmaceutical Preparations | 1 | 2013 | 1071 | 0.020 |
Why?
|
| Echocardiography | 1 | 2018 | 5097 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2009 | 1583 | 0.020 |
Why?
|
| Oxygen Isotopes | 1 | 1985 | 44 | 0.020 |
Why?
|
| Spectrum Analysis | 2 | 1985 | 451 | 0.020 |
Why?
|
| Genes, Protozoan | 1 | 2005 | 163 | 0.020 |
Why?
|
| MAP Kinase Kinase 3 | 1 | 2004 | 25 | 0.020 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 2004 | 25 | 0.020 |
Why?
|
| Familial Mediterranean Fever | 1 | 1985 | 61 | 0.020 |
Why?
|
| Metronidazole | 1 | 2005 | 217 | 0.020 |
Why?
|
| Risk | 1 | 2017 | 9679 | 0.020 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2005 | 298 | 0.020 |
Why?
|
| Equipment Design | 1 | 2012 | 3582 | 0.020 |
Why?
|
| tau Proteins | 1 | 2014 | 1860 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 2 | 1989 | 2167 | 0.010 |
Why?
|
| Cyclins | 1 | 2006 | 601 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2005 | 411 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 2006 | 0.010 |
Why?
|
| Synucleins | 1 | 2003 | 110 | 0.010 |
Why?
|
| Massachusetts | 1 | 2017 | 8662 | 0.010 |
Why?
|
| Cations, Divalent | 2 | 1980 | 166 | 0.010 |
Why?
|
| Sequence Homology | 1 | 2004 | 203 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2004 | 2455 | 0.010 |
Why?
|
| Virulence | 1 | 2007 | 1328 | 0.010 |
Why?
|
| Thrombosis | 1 | 2017 | 2966 | 0.010 |
Why?
|
| Chlortetracycline | 1 | 1983 | 5 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2014 | 3164 | 0.010 |
Why?
|
| Lewy Bodies | 1 | 2003 | 133 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2016 | 3067 | 0.010 |
Why?
|
| Ethanol | 1 | 1990 | 1337 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 1155 | 0.010 |
Why?
|
| Vasodilation | 1 | 1987 | 944 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2004 | 494 | 0.010 |
Why?
|
| Crystallization | 1 | 1984 | 525 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 2010 | 1149 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 3639 | 0.010 |
Why?
|
| Colchicine | 1 | 1984 | 242 | 0.010 |
Why?
|
| Critical Illness | 1 | 2015 | 2665 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 3 | 1990 | 223 | 0.010 |
Why?
|
| Research Design | 1 | 2018 | 5979 | 0.010 |
Why?
|
| Eukaryotic Cells | 1 | 2004 | 198 | 0.010 |
Why?
|
| Ionomycin | 1 | 1982 | 109 | 0.010 |
Why?
|
| Leukemia, Basophilic, Acute | 1 | 2002 | 15 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 936 | 0.010 |
Why?
|
| Diet | 2 | 2013 | 7923 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2018 | 6259 | 0.010 |
Why?
|
| Quinolines | 1 | 2007 | 719 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2006 | 2085 | 0.010 |
Why?
|
| Arteries | 1 | 1987 | 1118 | 0.010 |
Why?
|
| Length of Stay | 1 | 2015 | 6294 | 0.010 |
Why?
|
| Ethers | 1 | 1982 | 75 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2011 | 2440 | 0.010 |
Why?
|
| Lysosomes | 3 | 1984 | 893 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2005 | 926 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2002 | 255 | 0.010 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2002 | 90 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 1985 | 739 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2015 | 5978 | 0.010 |
Why?
|
| Ribonucleases | 1 | 2002 | 287 | 0.010 |
Why?
|
| RNA, Bacterial | 1 | 2003 | 391 | 0.010 |
Why?
|
| Plasminogen Activators | 1 | 2002 | 209 | 0.010 |
Why?
|
| Magnesium | 2 | 1982 | 813 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2004 | 647 | 0.010 |
Why?
|
| Reference Values | 1 | 1989 | 4982 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2006 | 1059 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 697 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2012 | 4328 | 0.010 |
Why?
|
| Retinal Diseases | 1 | 2007 | 683 | 0.010 |
Why?
|
| Cerebral Arteries | 1 | 2003 | 492 | 0.010 |
Why?
|
| Prostaglandins E | 3 | 1985 | 172 | 0.010 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2005 | 571 | 0.010 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2002 | 337 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2006 | 1353 | 0.010 |
Why?
|
| Cyclic GMP | 1 | 2002 | 408 | 0.010 |
Why?
|
| Alleles | 1 | 2012 | 6931 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2006 | 1144 | 0.010 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 2000 | 102 | 0.010 |
Why?
|
| Antigens, Helminth | 1 | 2000 | 64 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 2004 | 1078 | 0.010 |
Why?
|
| Risk Factors | 2 | 2004 | 72145 | 0.010 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2003 | 947 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2006 | 1114 | 0.010 |
Why?
|
| Temperature | 1 | 2006 | 2207 | 0.010 |
Why?
|
| Thalamus | 1 | 2005 | 1023 | 0.010 |
Why?
|
| Glioma | 1 | 1994 | 3388 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 2002 | 596 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 17400 | 0.010 |
Why?
|
| Corticosterone | 1 | 2000 | 310 | 0.010 |
Why?
|
| Phenobarbital | 1 | 1999 | 192 | 0.010 |
Why?
|
| Angiotensin II | 1 | 2002 | 881 | 0.010 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2000 | 215 | 0.010 |
Why?
|
| Misoprostol | 1 | 2000 | 95 | 0.010 |
Why?
|
| Rats, Inbred Strains | 2 | 1992 | 2191 | 0.010 |
Why?
|
| Leukocyte Elastase | 1 | 1999 | 113 | 0.010 |
Why?
|
| Sleep | 1 | 1994 | 4604 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2003 | 1465 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2002 | 1096 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2012 | 6249 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2002 | 1224 | 0.010 |
Why?
|
| Tuberculosis | 1 | 2008 | 1904 | 0.010 |
Why?
|
| Receptors, IgG | 1 | 1999 | 582 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2002 | 1780 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2002 | 1209 | 0.010 |
Why?
|
| Osmosis | 1 | 1994 | 113 | 0.010 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1995 | 293 | 0.010 |
Why?
|
| Exocytosis | 1 | 1995 | 353 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 3769 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2906 | 0.010 |
Why?
|
| Benzhydryl Compounds | 1 | 2000 | 840 | 0.010 |
Why?
|
| Inositol | 1 | 1994 | 216 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 1994 | 8829 | 0.010 |
Why?
|
| Thiazoles | 1 | 2000 | 1484 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 15494 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2005 | 2951 | 0.010 |
Why?
|
| Body Temperature | 1 | 1994 | 776 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2004 | 3843 | 0.010 |
Why?
|
| Sulfonamides | 1 | 1999 | 1932 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 1988 | 156 | 0.000 |
Why?
|
| Cheek | 1 | 1988 | 63 | 0.000 |
Why?
|
| Genotype | 1 | 2002 | 12946 | 0.000 |
Why?
|
| Hypoglycemic Agents | 1 | 2000 | 2866 | 0.000 |
Why?
|
| Mutation | 1 | 2011 | 29717 | 0.000 |
Why?
|
| Linolenic Acids | 1 | 1986 | 8 | 0.000 |
Why?
|
| Phorbol Esters | 1 | 1985 | 111 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2010 | 53187 | 0.000 |
Why?
|
| Muramidase | 1 | 1985 | 174 | 0.000 |
Why?
|
| alpha-Linolenic Acid | 1 | 1986 | 144 | 0.000 |
Why?
|
| Linoleic Acids | 1 | 1985 | 38 | 0.000 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1985 | 189 | 0.000 |
Why?
|
| Ileum | 1 | 1988 | 565 | 0.000 |
Why?
|
| Golgi Apparatus | 1 | 1987 | 410 | 0.000 |
Why?
|
| Insulin | 1 | 2000 | 6575 | 0.000 |
Why?
|
| Precipitin Tests | 1 | 1985 | 829 | 0.000 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1985 | 482 | 0.000 |
Why?
|
| Regional Blood Flow | 1 | 1987 | 1525 | 0.000 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 1984 | 304 | 0.000 |
Why?
|
| Hydrolases | 1 | 1984 | 139 | 0.000 |
Why?
|
| Membrane Lipids | 1 | 1984 | 248 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1992 | 4197 | 0.000 |
Why?
|
| Trachea | 1 | 1988 | 1075 | 0.000 |
Why?
|
| Antigens, Surface | 1 | 1985 | 1663 | 0.000 |
Why?
|
| Prostaglandin Endoperoxides, Synthetic | 1 | 1980 | 58 | 0.000 |
Why?
|
| Glucuronidase | 1 | 1982 | 207 | 0.000 |
Why?
|
| Egtazic Acid | 1 | 1980 | 173 | 0.000 |
Why?
|
| Epitopes | 1 | 1985 | 2569 | 0.000 |
Why?
|
| Calcium Channel Blockers | 1 | 1982 | 689 | 0.000 |
Why?
|
| Glycoproteins | 1 | 1985 | 2260 | 0.000 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1984 | 1820 | 0.000 |
Why?
|